Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2838524rdf:typepubmed:Citationlld:pubmed
pubmed-article:2838524lifeskim:mentionsumls-concept:C0026473lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0001407lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0028027lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0038836lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C0242417lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C1522492lld:lifeskim
pubmed-article:2838524lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:2838524pubmed:issue6lld:pubmed
pubmed-article:2838524pubmed:dateCreated1988-8-3lld:pubmed
pubmed-article:2838524pubmed:abstractTextHuman monocytes purified by elutriation were cultured for 3 d in Teflon bags with or without human recombinant interferon-gamma (rIFN gamma). The cells were then collected and used in suspension to determine the rate of stimulus-dependent superoxide or hydrogen peroxide formation as a measure of the NADPH-oxidase. The treatment with IFN gamma increased this rate two- to threefold when phorbol myristate acetate (PMA) was used as the stimulus. By contrast, no IFN gamma-dependent increase in superoxide production was observed when the cells were stimulated with different concentrations of the receptor agonist N-formyl-methionyl-leucyl-phenylalanine (f-Met-Leu-Phe) alone or in combination with another receptor agonist, platelet-activating factor (PAF). At optimum concentrations, f-Met-Leu-Phe elicited rates of superoxide formation that could not be exceeded under other stimulatory conditions including PMA after treatment with IFN gamma. It thus appears that f-Met-Leu-Phe can lead to maximum activation of the NADPH-oxidase, and that this response is not influenced by IFN gamma. Treatment with IFN gamma also failed to affect the affinity of PMA- or f-Met-Leu-Phe-stimulated oxidase for NADPH, the Km values being 30 to 40 microM under all conditions. IFN gamma did not alter the cellular levels of cytochrome b558, as measured by low-temperature spectroscopy, and protein kinase C, as measured by [3H]phorbol dibutyrate binding, and did not appreciably influence the stimulus-dependent increase of cytosolic free calcium. These results indicate that activation of human mononuclear phagocytes by IFN gamma does not affect the level and the kinetic properties of NADPH-oxidase or its activation by receptor agonists. They confirm, however, that IFN gamma enhances the respiratory burst response to PMA.lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:languageenglld:pubmed
pubmed-article:2838524pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2838524pubmed:statusMEDLINElld:pubmed
pubmed-article:2838524pubmed:monthJunlld:pubmed
pubmed-article:2838524pubmed:issn0021-9738lld:pubmed
pubmed-article:2838524pubmed:authorpubmed-author:BaggioliniMMlld:pubmed
pubmed-article:2838524pubmed:authorpubmed-author:ThelenMMlld:pubmed
pubmed-article:2838524pubmed:authorpubmed-author:WolfMMlld:pubmed
pubmed-article:2838524pubmed:issnTypePrintlld:pubmed
pubmed-article:2838524pubmed:volume81lld:pubmed
pubmed-article:2838524pubmed:ownerNLMlld:pubmed
pubmed-article:2838524pubmed:authorsCompleteYlld:pubmed
pubmed-article:2838524pubmed:pagination1889-95lld:pubmed
pubmed-article:2838524pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:meshHeadingpubmed-meshheading:2838524-...lld:pubmed
pubmed-article:2838524pubmed:year1988lld:pubmed
More...